Womens Health Diagnostics Market Report 2026

Womens Health Diagnostics Market Overview

• Womens Health Diagnostics market size has reached to $36.88 billion in 2025 • Expected to grow to $59.02 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Surge In Demand For Personalized Medicine Propels Growth In Women's Health Diagnostics Market • Market Trend: Advanced AI And Premium Ultrasound Innovation • North America was the largest region in 2025 and Asia-pacific is the fastest growing region.

What Is Covered Under Womens Health Diagnostics Market?

Women's health diagnostics refers to medical tests and procedures used to evaluate and diagnose various health conditions and diseases that specifically affect women. These diagnostics are important for identifying health issues early on and providing appropriate treatment and management to improve outcomes and quality of life. The main types of women's health diagnostics are accessories and consumables, diagnostic tests, and diagnostic devices. Accessories and consumables refer to various supplementary items and materials used in diagnostic procedures specifically related to women's health, and they are used to enhance the accuracy, convenience, and effectiveness of diagnostic tests and examinations in women. They are used in various applications such as osteoporosis testing, ovarian cancer testing (OVC), cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening and carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound testing by end users such as hospitals and clinics, diagnostic and imaging centers, homecare, and other end users.

What Is The Womens Health Diagnostics Market Growth Forecast?

The womens health diagnostics market size is expected to see strong growth in the next few years. It will grow to $59.02 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for personalized diagnostics, rising investments in precision testing technologies, expansion of home-based diagnostics, growing integration of ai analytics, increasing focus on preventive screening programs. Major trends in the forecast period include increasing adoption of advanced imaging and testing technologies, rising use of at-home diagnostic kits, growing integration of ai in diagnostic interpretation, expansion of genetic and hormonal testing, enhanced focus on early disease detection.

Global Womens Health Diagnostics Market Segmentation

1) By Type: Accessories And Consumables, Diagnostic Tests, Diagnostic Devices 2) By Application: Osteoporosis Testing, Ovarian Cancer Testing (OVC), Cervical Cancer Testing, Breast Cancer Testing, Pregnancy And Fertility Testing, Prenatal Genetic Screening And Carrier Testing, Infectious Disease Testing, Sexually Transmitted Diseases (STD) Testing, Ultrasound Tests 3) By End User: Hospitals And Clinics, Diagnostic And Imaging Centers, Homecare, Other End Users Subsegments: 1) By Accessories And Consumables: Test Kits, Sample Collection Devices, Reagents, Control Materials 2) By Diagnostic Tests: Blood Tests, Imaging Tests, Genetic Tests, Hormonal Tests 3) By Diagnostic Devices: Imaging Devices, Invasive Diagnostic Devices, Non-Invasive Diagnostic Devices, Monitoring Devices

What Is The Driver Of The Womens Health Diagnostics Market?

The growing demand for personalized medicine is expected to propel the growth of the women's health diagnostics market going forward. Personalized medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's own genes or proteins. Personalized medicine allows healthcare providers to create treatment plans that are specifically tailored to a woman's unique genetic, molecular, and clinical profile. This can involve targeted therapies based on genetic markers or specific biomarkers. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from 6 approvals in 2022, with the 2023 approvals also encompassing seven oncology therapies and three treatments targeting various other conditions. Therefore, the growing demand for personalized medicine is driving the growth of the women's health diagnostics market.

Key Players In The Global Womens Health Diagnostics Market

Major companies operating in the womens health diagnostics market are Becton Dickinson And Company, F. Hoffmann-La Roche AG, General Electric Company, Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Abbott Laboratories, BioMérieux SA, Hologic Inc., PerkinElmer Inc., Alere Inc., Carestream Health Inc., Procter & Gamble Co., Trinity Biotech plc, Medgyn Products Inc., URIT Medical Electronic Co. Ltd, Sonic Healthcare Limited, Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Genomic Health Inc., Invitae Corporation, Natera Inc., QIAGEN N.V., Opko Health Inc., Sysmex Corporation, Exact Sciences Corporation, Foundation Medicine Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc.

Global Womens Health Diagnostics Market Trends and Insights

Major companies operating in the women's health diagnostics market are focusing on product innovations, such as premium ultrasound systems, to sustain their position in the market. A premium ultrasound system refers to a sophisticated and advanced medical imaging device designed to capture detailed and high-quality images of internal structures within the human body. Premium ultrasound system is part of Samsung’s HERA platform, specifically tailored for obstetrics and gynecology. For instance, in February 2023, Samsung’s digital radiography and ultrasound business, a US-based company, unveiled the HERA W10 Elite, a cutting-edge women’s health ultrasound system. It comes equipped with a suite of artificial intelligence (AI) tools and clinical applications, marking a significant advancement in the diagnostic experience for women's health. HERA W10 Elite is equipped with advanced features such as MV-Flow for displaying the intensity of blood flow, BiometryAssist for convenient fetal growth parameter measurement, and precise analytic capabilities to assist clinicians in diagnosis.

What Are Latest Mergers And Acquisitions In The Womens Health Diagnostics Market?

In October 2024, Hologic, a US-based medical technology company, acquired Gynesonics, Inc. for an undisclosed amount. Through this acquisition, Hologic aims to expand its minimally invasive solutions for women's health, particularly for treating symptomatic uterine fibroids and heavy menstrual bleeding. By integrating the sonata system, Hologic seeks to improve patient outcomes and offer GYN surgeons a broader range of treatment options. This strategic move reinforces Hologic's commitment to innovation and growth in women's healthcare. Gynesonics is a US-based company specializing in innovative medical technologies for women's health, focusing on non-invasive treatments for uterine fibroids and offering women's health diagnostics.

Regional Outlook

North America was the largest region in the women's health diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global women's health diagnostics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Womens Health Diagnostics Market?

The women's health diagnostics market includes revenues earned by entities by providing women's health diagnostics, including pregnancy tests, breast imaging equipment, and hormone level tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Womens Health Diagnostics Market Report 2026?

The womens health diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the womens health diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.